XML 72 R49.htm IDEA: XBRL DOCUMENT v3.19.2
Revenue Recognition - Additional Information (Detail)
¥ in Billions
1 Months Ended 3 Months Ended 6 Months Ended 13 Months Ended
May 17, 2018
USD ($)
PerformanceObligation
Apr. 30, 2013
USD ($)
PerformanceObligation
Apr. 30, 2012
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2018
USD ($)
Jun. 30, 2019
USD ($)
PerformanceObligation
Milestone
Jun. 30, 2018
USD ($)
Milestone
Jun. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Apr. 30, 2013
JPY (¥)
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Deferred revenue, current       $ 26,473,000   $ 26,473,000   $ 26,473,000 $ 26,825,000  
Deferred revenue, non current       6,085,000   6,085,000   6,085,000 15,184,000  
Total revenue       5,208,000 $ 2,874,000 $ 9,590,000 $ 2,874,000      
Number of milestone event probable of occurrence or achieved | Milestone           0 0      
License and Milestone Fees [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Total revenue       5,208,000 $ 2,874,000 $ 9,450,000 $ 2,874,000      
Royalty [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Revenue from contract with customer           0        
VFMCRP Agreement [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Deferred revenue, current       26,473,000   26,473,000   26,473,000 26,825,000  
Deferred revenue, non current       6,085,000   6,085,000   6,085,000 15,184,000  
Receivables       0   0   0 0  
Other assets       0   0   0 0  
Deferred revenue $ 55,444,000               0  
Number of combined performance obligations for revenue recognized | PerformanceObligation 1                  
Number of performance obligations for revenue recognized | PerformanceObligation 2                  
upfront payment $ 50,000,000                  
Premium from sale of stock $ 5,444,000                  
Remaining performance obligations       $ 32,558,000   $ 32,558,000   $ 32,558,000    
Remaining performance obligation, expected timing of satisfaction, year       2020   2020   2020    
VFMCRP Agreement [Member] | License and Milestone Fees [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Total revenue       $ 5,208,000   $ 9,450,000   $ 22,886,000    
Maruishi and CKDP Agreements [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Receivables       0   0   0 0  
Other assets       0   0   0 0  
Deferred revenue       $ 0   $ 0   $ 0 $ 0  
Number of remaining performance obligations | PerformanceObligation           0        
Maruishi Agreement [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Number of performance obligations for revenue recognized | PerformanceObligation   2       2        
Premium from sale of stock   $ 337,000                
Upfront non-refundable, non-creditable license fee and premium from sale of stock   15,337,000                
Maruishi Agreement [Member] | Clinical Development and Regulatory Milestones [Member] | Maximum [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Remaining potential consideration   10,500,000                
Maruishi Agreement [Member] | One-time Sales Milestone [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Remaining potential consideration | ¥                   ¥ 1
Maruishi Agreement [Member] | License [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Estimated selling price   10,200,000                
Upfront payments on obligations   9,637,000                
Maruishi Agreement [Member] | R&D Services [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Estimated selling price   6,200,000                
Upfront payments on obligations   $ 5,700,000                
CKDP Agreement [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Premium from sale of stock     $ 83,000              
CKDP Agreement [Member] | Clinical Development and Regulatory Milestones [Member] | Maximum [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Remaining potential consideration     3,750,000              
CKDP Agreement [Member] | License [Member]                    
Revenue Recognition Multiple Deliverable Arrangements [Line Items]                    
Revenue from contract with customer     $ 646,000